Interstitial high-dose-rate brachytherapy combined with cervical dissection on head and neck cancer

Head and Neck

Volumn 27, Issue 12, 2005, Pages 1035-1041

  Assis Pellizzon, Antonio Cassio ^a   Dos Santos Novaes, Paulo Eduardo Ribeiro ^a   Conte Maia, Maria Aparecida ^a   Ferrigno, Robson ^a   Fogarolli, Ricardo ^a   Salvajoli, João Vitor ^a   Kowalski, Luiz Paulo ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

Author keywords

Acute morbidity; Brachytherapy; Head neck cancer; High dose rate; Interstitial implant; Late morbidity; Radiotherapy; Squamous cell carcinoma

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BRACHYTHERAPY; BRAZIL; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CERVICAL LYMPH NODE; CLINICAL ARTICLE; CONTROLLED STUDY; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FIBROSIS; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; INTERSTITIAL RADIATION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALE; MORBIDITY; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TREATMENT OUTCOME; ULCER; WOUND DEHISCENCE;

ADULT; AGED; BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MIDDLE AGED; NECK DISSECTION; PROGNOSIS; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SALVAGE THERAPY;

EID: 28244454215     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.20278     Document Type: Article

References (25)

1. Franchin G, Gobitti C, Minatel E, et al. Simultaneous radiochemotherapy in the treatment of inoperable, locally advanced head and neck cancers. A single-institution study. Cancer 1995;75:1025-1029.
2. Konski A, Berkey BA, Kian Ang K, Fu KK. Effect of education level on outcome of patients treated on Radiation Therapy Oncology Group Protocol 90-03. Cancer 2003;98:1497-1503.
3. Spitz MR. Epidemiology and risk factors for head and neck cancer. Semin Oncol 1994;21:281-288.
4. Jay S, Cooper JS, Pajak TF, et al. Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-1944.
5. Jones AS, Khan H. The patterns and treatment of recurrence following radiotherapy for carcinoma of the oral cavity. Clin Otolaryngol 1993;18:14-18.
6. Johansen LV, Grau C, Overgaard J. Supraglottic carcinoma: patterns of failure and salvage treatment after curatively intended radiotherapy in 410 consecutive patients. Int J Radiat Oncol Biol Phys 2002;53:948-958.
7. Mazeron JJ, Noel G, Simon JM, Racadot S, Jauffret E. Brachytherapy in head and neck cancers. Cancer Radiother 2003;7:62-72.
8. Novaes PERS, Gentil AC, Lima CGB Jr, Pellizzon ACA, Kowalski LP. Possibilities of high dose rate brachytherapy on treatment of head and neck cancer. In: Moraes M, Brentani R, Bevilacqua R, editors. 17th International Cancer Congress. Bologna: Monduzzi Editori (International Proceedings Division); 1998. pp 537-540.
9. Brasil. Ministério da Saúde. Secretaria Nacional de Assistência à Saúde. Instituto Nacional do Câncer. Estimativa de incidência e mortalidade por câncer no Brasil 2003. Rio de Janeiro: INCA; 2003. p 3-29.
10. Jemal A, Tiwari RC, Murray T, et al. Cancer statistics, 2004. CA Cancer J Clin 2004;54:8-29.
11. American Joint Committee on Cancer. Purposes and principles of staging. In: AJCC cancer staging manual, 5th ed. Philadelphia: Lippincott-Raven; 1997.
12. Dutreix A, Marinello G. The Paris system. In: Pierquin B, Wilson J, Chassagne W, editors. Modern brachytherapy. Masson, New York; 1987.
13. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
14. Mantel N, Haenszel W. Chi-square tests with one degree of freedom: extensions of the Mantel-Haenszel procedure. J Am Stat Assoc 1963;58:690-700.
15. Mendenhall WM, Amdur RJ, Siemann DW, Parsons JT. Altered fractionation in definitive irradiation of squamous cell carcinoma of the head and neck. Curr Opin Oncol 2000;12:207-214.
16. Mazeron JJ, Noel G, Simon JM. Head and neck brachytherapy. Semin Radiat Oncol 2002;12:95-108.
17. Lapeyre M, Bollet MA, Racadot S, et al. Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins. Head Neck 2004;26:216-223.
18. Garg M, Beitler JJ. Controversies in management of the neck in head and neck cancer. Curr Treat Options Oncol 2004;5:35-40.
19. Mendenhall WM, Villaret DB, Amdur RJ, Hinerman RW, Mancuso AA. Planned neck dissection after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck 2002;24:1012-1018.
20. Pathak I, Gilbert R, Davidson J, Brit D. Efficacy of surgical salvage for advanced neck metastases after radiotherapy failure. J Otolaryngol 2000;29:340-343.
21. Lau HY, Hay JH, Flores AD, Threlfall WJ. Seven fractions of twice daily high dose-rate brachytherapy for node-negative carcinoma of the mobile tongue results in loss of therapeutic ratio. Radiother Oncol 1996;39:15-18.
22. Takacsi-Nagy Z, Oberna F, Polgar C, Somogyi A, Major T, Nemeth G. The importance of interstitial radiotherapy in the treatment of the base of tongue tumors: a retrospective analysis. Neoplasma 2001;48:76-81.
23. Leung TW, Wong VY, Kwan KH, et al. High dose rate brachytherapy for early stage oral tongue cancer. Head Neck 2002;24:274-278.
24. Vikram B, Mishra S. Permanent iodine-125 implants in postoperative radiotherapy for head and neck cancer with positive surgical margins. Head Neck 1994;16:155-157.
25. Beitler JJ, Smith RV, Silver CE, et al. Close or positive margins after surgical resection for the head and neck cancer patient: the addition of brachytherapy improves local control. Int J Radiat Oncol Biol Phys 1998;40:313-317.